BRN Discussion Ongoing

Kachoo

Regular
Imo, this is the most important slide in Todd's presentation:

View attachment 51046


You would think if nothing was happening, or not on the horizon, that these names would not appear on the slide. If Valeo, or Mercedes, or NASA had stalled or decided to go with a different/competeitor technology, then they would not be listed here? If the "early adoption" of the technology was not true, or moving forward, or they decided to go with an alternative technology they would ask Brainchip to remove their name.

The names are still there, and that is good and big things are going to happen soon!

(Ford's name doesn't appear in the list, and that is ok - they are the perhaps the ones who have put their project on hold........, ie a point of difference with this slide)
Hey HG your absolutely correct.

One thing I would say about Ford is that they have always wanted to be annomynous but with LD putting out that ASX news about a Detroit automaker news has to be updated with a name. So I would say after that they were on a very thin line with Ford. I would think based on Tony's communication about the list Ford is still doing what they do but we won't see anything or hear much from them IMO.
Cheers
 
  • Like
  • Thinking
Reactions: 8 users

Boab

I wish I could paint like Vincent
  • Like
  • Fire
  • Love
Reactions: 12 users

Frangipani

Top 20
A few more news articles from the university


Orebro University is in Sweden.
Wasn't aware we had a connection with them?
The tentacles keep reaching out👍👍

Hi Pom down under and Boab,

the tweet (or whatever it is called these days) BrainChip published yesterday is unfortunately somewhat misleading - as far as I understand it, there is no actual collaboration with Örebro University, even though by using the Swedish uni’s coat of arms, the tweet makes it look like there is. Our company merely utilised a decade-old dataset collected by Örebro University researchers:

6D0E3B7A-BFC9-4A4E-AE67-3D034115065B.jpeg


FABADA86-6285-4532-88EA-18FEF8511996.jpeg


Excerpt from my earlier post, linking to the research paper found on the BrainChip website:

Overview:
In this research, we utilized the ‘bacteria in blood’ dataset, which was previously collected by the Mednose project team at Örebro University. Their project was centred on the early detection of different bacterial species in blood, by identifying the unique chemical signatures they emit during initial growth phases.The collection was carried out using the NST 3220 Emission Analyzer, a sophisticated electronic nose device developed by Applied Sensors, equipped with a combined array of 22 metal-oxide semiconductor (MOS) and MOSFET sensors. The project’s objective was to distinguish between ten types of bacteria in blood samples, and for this purpose, a comprehensive dataset of 1200 samples was created, with 120 samples representing each bacterial species. For an in-depth understanding of the electronic nose experiments and the sampling protocols, a detailed description is available in the work by Trincavelli et al. titled “Direct identification of bacteria in blood culture samples using an electronic nose,” published in the IEEE Transactions on Biomedical Engineering

⬇️


5E93B362-5083-4109-ACC0-F55F4C2C5B5F.jpeg
 
Last edited:
  • Like
  • Thinking
  • Love
Reactions: 17 users

Diogenese

Top 20
Hi Pom down under and Boab,

the tweet (or whatever it is called these days) BrainChip published yesterday is unfortunately somewhat misleading - as far as I understand it, there is no actual collaboration with Örebro University, even though by using the Swedish uni’s coat of arms, the tweet makes it look like there is. Our company merely utilised a decade-old dataset collected by Örebro University researchers:

View attachment 51050

View attachment 51051

Excerpt from my earlier post, linking to the research paper found on the BrainChip website:

Overview:
In this research, we utilized the ‘bacteria in blood’ dataset, which was previously collected by the Mednose project team at Örebro University. Their project was centred on the early detection of different bacterial species in blood, by identifying the unique chemical signatures they emit during initial growth phases.The collection was carried out using the NST 3220 Emission Analyzer, a sophisticated electronic nose device developed by Applied Sensors, equipped with a combined array of 22 metal-oxide semiconductor (MOS) and MOSFET sensors. The project’s objective was to distinguish between ten types of bacteria in blood samples, and for this purpose, a comprehensive dataset of 1200 samples was created, with 120 samples representing each bacterial species. For an in-depth understanding of the electronic nose experiments and the sampling protocols, a detailed description is available in the work by Trincavelli et al. titled “Direct identification of bacteria in blood culture samples using an electronic nose,” published in the IEEE Transactions on Biomedical Engineering

⬇️


View attachment 51052
Hi Frangipani,

In all NN applications, the model library is a crucial part of the setup. It is the information against which the test samples are to be compared. A NN cannot function without the model.

Maybe the Orebro Uni requires acknowledgement of the use of its database in exchange for access to their proprietary database, and they may require the display of their logo as acknowledgement of their authorship of the data.
 
  • Like
  • Fire
  • Love
Reactions: 27 users

Frangipani

Top 20
Hi Frangipani,

In all NN applications, the model library is a crucial part of the setup. It is the information against which the test samples are to be compared. A NN cannot function without the model.

Maybe the Orebro Uni requires acknowledgement of the use of its database in exchange for access to their proprietary database, and they may require the display of their logo as acknowledgement of their authorship of the data.
You are right, that’s indeed a possible explanation for the uni’s coat of arms being displayed.

But I would venture a guess that the vast majority of people seeing that tweet would automatically assume it signified there was an existing research collaboration between our company and Örebro University and visualise biomedical researchers at the Swedish uni experimenting with Akida. Which is clearly not what this press release is about.
 
  • Like
  • Fire
Reactions: 9 users

Learning

Learning to the Top 🕵‍♂️
Hi Pom down under and Boab,

the tweet (or whatever it is called these days) BrainChip published yesterday is unfortunately somewhat misleading - as far as I understand it, there is no actual collaboration with Örebro University, even though by using the Swedish uni’s coat of arms, the tweet makes it look like there is. Our company merely utilised a decade-old dataset collected by Örebro University researchers:

View attachment 51050

View attachment 51051

Excerpt from my earlier post, linking to the research paper found on the BrainChip website:

Overview:
In this research, we utilized the ‘bacteria in blood’ dataset, which was previously collected by the Mednose project team at Örebro University. Their project was centred on the early detection of different bacterial species in blood, by identifying the unique chemical signatures they emit during initial growth phases.The collection was carried out using the NST 3220 Emission Analyzer, a sophisticated electronic nose device developed by Applied Sensors, equipped with a combined array of 22 metal-oxide semiconductor (MOS) and MOSFET sensors. The project’s objective was to distinguish between ten types of bacteria in blood samples, and for this purpose, a comprehensive dataset of 1200 samples was created, with 120 samples representing each bacterial species. For an in-depth understanding of the electronic nose experiments and the sampling protocols, a detailed description is available in the work by Trincavelli et al. titled “Direct identification of bacteria in blood culture samples using an electronic nose,” published in the IEEE Transactions on Biomedical Engineering

⬇️


View attachment 51052
Hi Frangipani,

I agree with what Dio said above, as this media release didn't say Brainchip (partners/ collaborate) with Örebro University. It's state this:

With findings achieved through studies by BrainChip Research, “Finding Bacteria in the Blood: Scaling a Hardware-Driven Neuromorphic Solution for Real-World E-Nose Applications” presents how a hardware-based, low-power neuromorphic solution can be combined with electronic sensors to create compelling real-world healthcare solutions that are cost-effective, portable and accurate. These assisted devices could significantly speed up disease diagnosis in remote locations, or even outside of traditional clinical facilities.

The paper explores a blood dataset collected as part of the Mednose project at Örebro University. The classifier model developed using Akida™ was able to identify ten different bacteria species in blood samples with a classification accuracy of 97.42%, outperforming previous implementations.

“Leveraging neuromorphic hardware to provide portable, power-efficient solutions for use in the identification of sensory data is a game-changer for a plethora of practical applications, such as e-nose systems,” said Anup Vanarse, Research Scientist at BrainChip. “This latest research paper shows how Akida’s olfactory analysis technology allows for efficient and accurate detection of various strains of bacteria in blood to help with important disease diagnosis. Incorporating beneficial AI within sensory devices will provide the means for massive breakthroughs in the healthcare industry.”


I understand it's as Brainchip Research has came to this conclusion of by using AKD1000 to analyse the blood samples and achieve 97.42% again the Örebro University paper.

Learning 🪴
 
  • Like
  • Love
Reactions: 24 users

Diogenese

Top 20
You are right, that’s indeed a possible explanation for the uni’s coat of arms being displayed.

But I would venture a guess that the vast majority of people seeing that tweet would automatically assume it signified there was an existing research collaboration between our company and Örebro University and visualise biomedical researchers at the Swedish uni experimenting with Akida. Which is clearly not what this press release is about.
That's probably right, but I think there is more benefit for the Uni than Bainchip. Having their decade-old research not merely cited, but used, in relation to THE chip of the hour is a feather in their cap.

And it also does serve to expand awareness of Akida in Sweden. Who knows ... it may even trigger further cooperation with the Uni.

So it's a win-win.

And the public who get to read it, present company excepted, will mostly be involved in the relevant field of research.
 
  • Like
  • Fire
  • Love
Reactions: 31 users
Yep happens every year… It would be nice if it was instos getting set though 😀
Ohh they are getting set and have been buying up for months now!
 
  • Like
  • Fire
Reactions: 5 users

Frangipani

Top 20
Hi Frangipani,

I agree with what Dio said above, as this media release didn't say Brainchip (partners/ collaborate) with Örebro University. It's state this:

With findings achieved through studies by BrainChip Research, “Finding Bacteria in the Blood: Scaling a Hardware-Driven Neuromorphic Solution for Real-World E-Nose Applications” presents how a hardware-based, low-power neuromorphic solution can be combined with electronic sensors to create compelling real-world healthcare solutions that are cost-effective, portable and accurate. These assisted devices could significantly speed up disease diagnosis in remote locations, or even outside of traditional clinical facilities.

The paper explores a blood dataset collected as part of the Mednose project at Örebro University. The classifier model developed using Akida™ was able to identify ten different bacteria species in blood samples with a classification accuracy of 97.42%, outperforming previous implementations.

“Leveraging neuromorphic hardware to provide portable, power-efficient solutions for use in the identification of sensory data is a game-changer for a plethora of practical applications, such as e-nose systems,” said Anup Vanarse, Research Scientist at BrainChip. “This latest research paper shows how Akida’s olfactory analysis technology allows for efficient and accurate detection of various strains of bacteria in blood to help with important disease diagnosis. Incorporating beneficial AI within sensory devices will provide the means for massive breakthroughs in the healthcare industry.”


I understand it's as Brainchip Research has came to this conclusion of by using AKD1000 to analyse the blood samples and achieve 97.42% again the Örebro University paper.

Learning 🪴
Hi Learning,

I think you misunderstood my post: I never claimed the media release said there was a collaboration between our company and Örebro University. In fact, I myself quoted part of the research paper to prove my point. My original post was in reaction to two forum members who may not have actually read the media release, but had obviously concluded just from seeing that tweet displaying both logos that it was about some kind of collaboration with Örebro University researchers utilising Akida.

I was simply trying to stick to the facts and correct that assumption. And that’s why I called the tweet ‘somewhat misleading’, as IMO it is understandable why someone just looking at the tweet could come to that conclusion and might interpret too much into it. And these kind of misinterpretations will ultimately play into the hands of downrampers. That’s all. Apart from that ambiguous use of Örebro University’s coat of arms, I love the announcement.

Cheers,
Frangipani

P.S.: It just occurred to me that ‘misleading’ may not have been the ideal choice of adjective here, as it could imply intention? 🤔 The word I would use in German (‘missverständlich’) is much more neutral.
 
  • Like
  • Love
  • Fire
Reactions: 13 users
Obviously it’s good that BRN is updating us regarding olfactory devices but it’s nothing new. I don’t get the excitement. Back then we were debating about the possibility of having a product launched this year. Doing studies with other universities or using their samples is no valuable progress at this point.
For the newer investors this is/ was what I’m talking about.

 
  • Like
  • Fire
  • Love
Reactions: 6 users

Diogenese

Top 20
Hi Learning,

I think you misunderstood my post: I never claimed the media release said there was a collaboration between our company and Örebro University. In fact, I myself quoted part of the research paper to prove my point. My original post was in reaction to two forum members who may not have actually read the media release, but had obviously concluded just from seeing that tweet displaying both logos that it was about some kind of collaboration with Örebro University researchers utilising Akida.

I was simply trying to stick to the facts and correct that assumption. And that’s why I called the tweet ‘somewhat misleading’, as IMO it is understandable why someone just looking at the tweet could come to that conclusion and might interpret too much into it. And these kind of misinterpretations will ultimately play into the hands of downrampers. That’s all. Apart from that ambiguous use of Örebro University’s coat of arms, I love the announcement.

Cheers,
Frangipani

P.S.: It just occurred to me that ‘misleading’ may not have been the ideal choice of adjective here, as it could imply intention? 🤔 The word I would use in German (‘missverständlich’) is much more neutral.
... and this is just one small problem with which AGI will have to wrestle.
 
  • Like
  • Fire
Reactions: 6 users

Glen

Regular
Does anyone know if Grayscale AI is working with us?
 
  • Like
Reactions: 1 users

Tothemoon24

Top 20

Great little ✅ for the mighty chip​

Thinking at the edge: How neuromorphic computing empowers edge devices​

Nov 29, 2023 | Abhishek Jadhav
CATEGORIES Edge Computing News | Hardware
Thinking at the edge: How neuromorphic computing empowers edge devices

As experts in the industry believe that Moore’s Law and Dennard scaling is coming to an end, it becomes clear that the traditional approach to improving computer performance has reached its limits. To address these limitations, neuromorphic computing has emerged as a promising solution. Coined by Carver Mead in the late 1980s, the term “neuromorphic” refers to a computing approach inspired by the brain, combining analog and digital components.
Over recent years, the field of neuromorphic computing has expanded, particularly in its application to deep learning and machine learning. When we compare neuromorphic computers to von Neumann machines, which use separate CPUs and memory units, running programs based on explicit instructions, the difference is significant. Neuromorphic computers are inspired from neurons and synapses.

One key advantage of neuromorphic hardware lies in its integration of processing and memory, which helps mitigate the von Neumann bottleneck that can slow down the data processing speed. This integration also reduces the need for frequent data access from main memory, a common operation in conventional computing systems that consumes a substantial amount of energy.

In this article, we will explore the convergence of neuromorphic computing with edge devices and explore its potential benefits in distributed edge computing. Additionally, we will examine industry contributions to the field of neuromorphic computing within the specific context of edge infrastructure. Finally, we will discuss the market opportunities and the future prospects of this advanced computing technology.

Neuromorphic computing meets edge devices​

One of the most interesting aspects of neuromorphic computing lies in its ability to operate with low power consumption. This capability can be attributed to two key factors – the event-driven nature of neuromorphic systems and their massive parallelism. Unlike traditional computing hardware, which continuously consumes power, neuromorphic computers only engage in computations when there are specific events or spikes to process. Its inherent parallelism allows many neurons and synapses to operate simultaneously, meaning that only a small portion of the system is active at any given time, while the rest remains idle.

Both of these factors have significant implications for the efficiency and effectiveness of computing in edge environments. The event-driven characteristic is particularly advantageous when dealing with thousands of edge devices deployed in remote settings where data is generated sporadically or in response to specific events. For instance, in scenarios such as oil and gas plants, sensors may only produce data when certain parameters exceed normal values, or surveillance cameras may transmit data upon detecting motion. Event-driven processing aligns well with the need for efficient utilization of computational resources and the minimization of power consumption, which is the case of edge computing environments.

Similarly, the concept of massive parallelism holds promise for edge computing. Many edge devices now incorporate multi-core processors or specialized AI accelerators, enabling them to engage in parallel processing of tasks. Edge computing can leverage this feature to execute resource-intensive AI computations concurrently, thereby delivering high performance and quick responses for mission-critical applications. The massive parallelism enables edge devices to reduce latency, provide real-time feedback, and take data-driven actions to enhance operational efficiency within the ecosystem.

Industry contributes to embedded intelligence at the edge​

Initially, a significant portion of research and industrial efforts in the field of neuromorphic hardware primarily focused on large-scale implementations that weren’t particularly suitable for edge platforms. However, Intel disrupted this landscape by introducing Loihi, a neuromorphic computing hardware platform based on open-source software frameworks designed for the development of intelligent computing applications.

Intel continued its development in advancing neuromorphic technology, which led to the launch of Loihi’s second-generation, which had been developed utilizing Intel’s 4th-generation pre-production process. In this iteration, the company introduced programmable neuron models and a generalized spike messaging system, thereby opening doors to a wide array of neural network models that can be trained in deep learning.

Another embedded manufacturer in the field of commercial neuromorphic computing hardware, BrainChip recently unveiled its second-generation Akida IP solution, built on the neuromorphic principles, with a claim of delivering low-power performance in compact edge devices. This new generation enhances energy efficiency by supporting 8-bit weights, activations, and long-range skip connections, thereby making complex neural networks feasible on edge devices.

Amid all the buzz around these developments in neuromorphic hardware, it is essential to consider their future in the context of the exponential growth of generative AI, which heavily relies on cloud computing resources. As the industry moves toward hybrid AI solutions, the demand for more capable and efficient computing at the network edge becomes increasingly evident.

Neuromorphic computing hardware, such as Akida, get attention for their temporal event-based neural networks that support vision transformers, thus ensuring high accuracy for large language models. The future of these advanced computing technologies holds promise as they play a key role in addressing the evolving landscape of AI and edge computing.

Outlook on neuromorphic computing at the edge​

In its 2023 report, Gartner highlights four emerging technologies expected to disrupt industries over the next three to eight years, with neuromorphic computing occupying the top position. According to the market research firm, neuromorphic computing is identified as a crucial enabler that will make a significant impact on existing products and markets.

While the continuous evolution of computing hardware is a given, experts believe that there are opportunities to achieve unprecedented levels of algorithmic performance, particularly in terms of speed and energy efficiency, through the utilization of neuromorphic computers. More specifically, graph algorithms and optimization tasks stand to benefit significantly from the extensive parallelism and event-driven operations inherent to neuromorphic computing.

It is anticipated that the growth of neuromorphic computing will play an important role in supporting the requirements of generative AI. The trajectory of neuromorphic computing’s future hinges on the maturation of the technology to meet the demands of the next generation of intelligent applications.
 
  • Like
  • Love
  • Fire
Reactions: 48 users

Esq.111

Fascinatingly Intuitive.
it seems that we are added into the MSCI Australia index.
View attachment 51038
Good Morning Stan9614 & Fellow Chippers ,

Stan , thankyou for providing the above info.... explanation.... for the volume increase yesterday.

Found this article on MSCI which I found rather interesting.

Worth reading the whole article, but for the time poor amoungst us, my two takeaways from article...

1, MSCI acts as a base for ETFs, as of Q4 2022 there were $14,970,000,000,000.00
Or $14.97 TRILLION in assets under management benchmarked to the firms indexes.

2, Each index in the MSCI family is reviewed quarterly & rebalanced two times per year.

Thanks once again Stan.




Needless to say, Morgan Stanley Capital International ( MSCI ) analysis is held to a higher degree than the odd article written by the Fickle Pickle .

Regards,
Esq.
 
Last edited:
  • Like
  • Fire
  • Love
Reactions: 54 users

Learning

Learning to the Top 🕵‍♂️
Hi Learning,

I think you misunderstood my post: I never claimed the media release said there was a collaboration between our company and Örebro University. In fact, I myself quoted part of the research paper to prove my point. My original post was in reaction to two forum members who may not have actually read the media release, but had obviously concluded just from seeing that tweet displaying both logos that it was about some kind of collaboration with Örebro University researchers utilising Akida.

I was simply trying to stick to the facts and correct that assumption. And that’s why I called the tweet ‘somewhat misleading’, as IMO it is understandable why someone just looking at the tweet could come to that conclusion and might interpret too much into it. And these kind of misinterpretations will ultimately play into the hands of downrampers. That’s all. Apart from that ambiguous use of Örebro University’s coat of arms, I love the announcement.

Cheers,
Frangipani

P.S.: It just occurred to me that ‘misleading’ may not have been the ideal choice of adjective here, as it could imply intention? 🤔 The word I would use in German (‘missverständlich’) is much more neutral.
Hi Frangipani,

The point I was making is the tweet/ media release wasn't 'missverständlich'. It's information (words) in the tweet/ media release that informative.

My apologies if I have misunderstood your post ❤️.

Learning 🪴
 
  • Like
  • Fire
Reactions: 11 users

Ethinvestor

Regular
Good Morning Chippers,

Would appear NO SHORTS TAKEN OUT on Friday.

Makes two consecutive days.

Feeling a little exited .


Regards,
Esq.
Where can you look up these infos about shorts ? Thx
 
  • Like
Reactions: 2 users

Esq.111

Fascinatingly Intuitive.
Morning Ethinvestor ,

1, ASX daily shorts report , 1 day old data.displays short no taken out on the day.
Updated after 11:00 🇦🇺 East Coast time.

2, Shortman , gives a simple list , chart and ranking.


There are several others ....

Regards,
Esq.
 
Last edited:
  • Like
  • Love
  • Fire
Reactions: 8 users

buena suerte :-)

BOB Bank of Brainchip
Wow what a day in the US !!!!

1701379859739.png

And positive for Europe

1701380789476.png
 
Last edited:
  • Like
  • Fire
Reactions: 11 users

buena suerte :-)

BOB Bank of Brainchip
  • Like
  • Fire
  • Love
Reactions: 13 users

buena suerte :-)

BOB Bank of Brainchip
  • Like
  • Fire
  • Love
Reactions: 25 users
Top Bottom